<table> <tbody> <tr> <td> <p><strong>POSITION SUMMARY</strong></p> </td> </tr> <tr> <td> <p>The Area Medical Director (AMD) is a senior physician leader embedded within a defined geography (Northeast, East, Central, or West) to serve as Natera's primary MD-to-MD clinical presence across the community oncology market. This role addresses the intersection of medical affairs, field execution, and scientific credibility — driving engagement with community oncologists, KOLs, and cross-functional field teams to accelerate appropriate utilization of Natera's oncology portfolio, including Signatera and Altera.</p> <br> <p>The AMD owns regional medical strategy, leads cross-functional field partnerships, and operates with high autonomy to define and execute area priorities. The AMD functions without a defined playbook, translates business strategy into field-level action, and surfaces clinical intelligence that informs both commercial execution and development priorities. This is a 50% field-based role.</p> </td> </tr> <tr> <td> <p><strong>PRIMARY RESPONSIBILITIES</strong></p> </td> </tr> <tr> <td> <p>MD-Level Field Engagement</p> <p>● Execute 12–18 MD-level engagements per quarter across defined geography, with at least 50% concentrated in top strategic community accounts.</p> <p>● Maintain field presence of at least 4 ride days per month, prioritizing and overseeing area high-value and "platinum" accounts, including lost/down account retrieval. Responsible/accountable for oversight and coordination with these accounts with Associate AMD. </p> <p>● Establish and maintain contact with the medical lead in the top 20 area accounts; engage 100% of flagged accounts within 10 business days.</p> <p> </p> <p>Cross-Functional Medical Leadership</p> <p>● Serve as the primary MD triage point for escalated area medical inquiries, acknowledging at least 90% within 48 hours with 100% closed-loop documentation in Salesforce.</p> <p>● Partner with MSL managers, Area Sales Directors, and Area Marketing Directors through structured bi-weekly and monthly cadences to align scientific messaging and commercial strategy.</p> <p>● Participate in at least 75% of high-priority account strategy reviews and area/regional planning sessions; co-own quarterly business reviews with MSL leadership.</p> <ul> <li>Proficiency with and current understanding of Natera’s evidence generation portfolio and ability to speak to/escalate questions or issues coming from area accounts.</li> </ul> <p> </p> <p>Scientific Communication and Education</p> <p>● Host, present, or observe at least 12 regional educational programs per quarter targeting high-impact community accounts.</p> <p>● Lead development of at least one educational initiative per cycle (physician-facing, patient-facing, or via webinar/podcast); complete annual recurrent speaker training.</p> <p>● Ensure consistent, compliant scientific positioning across field activities; document objection-handling themes and manage escalation to histology-specific Medical Directors where appropriate.</p> <p> </p> <p>Clinical Development Contribution</p> <p>● Identify and document field-driven evidence generation opportunities; surface at least one histology-specific clinical trial concept per year in collaboration with the CMO and histology Medical Director teams.</p> <p>● Generate at least 3 actionable regional insights per quarter in quarterly written reports submitted prior to manager review.</p> <p>● Identify at least 3 qualified KOL collaboration leads per quarter, including IST/RWE prospects, documented in Salesforce.</p> <p> </p> <p>Performs other duties as assigned.</p> </td> </tr> <tr> <td> <p><strong>QUALIFICATIONS</strong></p> </td> </tr> <tr> <td> <p>Required:</p> <p>● M.D. or D.O. with board certification in oncology, hematology, or a directly related clinical specialty.</p> <p>● Minimum 5–8 years of related clinical or medical affairs experience following board certification (HM5 level; equivalent field experience accepted).</p> <p>● Demonstrated proficiency across multiple tumor histologies and working knowledge of the molecular residual disease (MRD) diagnostic landscape.</p> <p>● Experience in a field-based medical affairs, clinical development, or medical education role within oncology diagnostics, pharma, or biotech.</p> <p>● Proven ability to communicate complex clinical data to community oncologist audiences.</p> <p> </p> <p>Preferred:</p> <p>● Direct experience with cfDNA-based or MRD testing platforms (e.g., Signatera, ctDNA-based assays).</p> <p>● Prior experience in a cross-functional field role collaborating with commercial, MSL, and marketing teams.</p> <p>● Experience contributing to clinical trial design, IST development, or real-world evidence programs.</p> </td> </tr> <tr> <td> <p><strong>KNOWLEDGE, SKILLS, AND ABILITIES</strong></p> </td> </tr> <tr> <td> <p>Technical:</p> <p>● Deep clinical fluency across multiple solid tumor histologies and understanding of MRD biology, assay methodology, and clinical application in oncology management.</p> <p>● Working